---
permalink: /
title: "Biography"
excerpt: "About Xinyue Qi"
author_profile: true
redirect_from: 
  - /about/
  - /about.html
---
Xinyue Qi joins the Virology Biostatistics team in Clinical Data Science at [Gilead Sciences](https://www.gilead.com/) in 2022. She came from [Incyte Corporation](https://www.incyte.com/), where she started out as *Principal Biostatistician* focusing on phase II oncology/hematology clinical studies across multiple indications with regulatory submission experiences.

Prior to Incyte, she was a graduate research assistant at [the University of Texas MD Anderson Cancer Center](https://www.mdanderson.org/) and completed her doctoral degree in Biostatistics at [the University of Texas Health Science Center at Houston](https://www.uth.edu/) under the supervision of 
[Dr. Shouhao Zhou](https://sites.psu.edu/szhou/) in the Department of Public Health Sciences at Penn State College of Medicine  and [Dr. Christine B. Peterson](https://odin.mdacc.tmc.edu/~cbpeterson/) in the Department of Biostatistics at the University of Texas MD Anderson Cancer Center. She graduated from School of Medicine at [Duke University](https://duke.edu/) with a *masterâ€™s* degree in Biostatistics and [University of Illinois at Urbana-Champaign](https://illinois.edu/) with a *bachelor's* degree in Molecular and Cellular Biology.

Her research interests span the topics of Bayesian modeling for censored data, (network) meta-analysis with applications to cancer immunotherapies, and evaluating the safety & efficacy of treamtent options in patients with hematological malignancies.
